Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person * Shah Chetan	2. Date of Event Requiring Statement (MM/DD/YYYY) 6/18/2013	3. Issuer Name and Ticker or Trading Symbol AETHLON MEDICAL INC [AEMD]
(Last)        (First)        (Middle) 8910 UNIVERSITY CENTER LANE, SUITE 660	4. Relationship of Reporting Person(s) to Issuer (Check all applicable) __ X __ Director                            _____ 10% Owner _____ Officer (give title below)          _____ Other (specify below)
(Street) SAN DIEGO, CA 92122        (City)              (State)              (Zip)	5. If Amendment, Date Original Filed (MM/DD/YYYY)	6. Individual or Joint/Group Filing (Check Applicable Line) _ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	8750000	D

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Common Stock Purchase Warrants	3/29/2012	3/29/2019	Common Stock	937500	$0.125	D
Common Stock Purchase Warrants	6/19/2012	6/19/2019	Common Stock	1111111	$0.108	D
Common Stock Purchase Warrants	8/29/2012	8/29/2019	Common Stock	534723	$0.120	D
Common Stock Purchase Warrants	11/12/2012	11/12/2019	Common Stock	666667	$0.093	D
Common Stock Purchase Warrants	2/11/2013	2/11/2020	Common Stock	333333	$0.096	D
Common Stock Purchase Warrants	3/14/2013	3/14/2020	Common Stock	333333	$0.115	D
Common Stock Purchase Warrants	6/14/2013	6/14/2020	Common Stock	333333	$0.121	D
10% Convertible Note	(1)	10/9/2013   (2)	Common Stock	3465909	$0.088	D

Explanation of Responses:
( 1)	Unpaid principal and accrued interest on the note are convertible at Dr. Shah's option into common stock only if the note is not repaid by October 9, 2013. In that event, unpaid principal and accrued interest may be converted into common stock at $0.088/share. In addition, upon conversion of the note, Dr. Shah would receive warrants to purchase that number of shares of common stock equal to 50% of the amount of principal and interest being converted divided by $0.088, with such warrants being exercisable at a price of $0.132/share.
( 2)	Maturity date.

Reporting Owners
Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
Shah Chetan 8910 UNIVERSITY CENTER LANE, SUITE 660 SAN DIEGO, CA 92122	X

Signatures
/s/ Chetan S. Shah, M.D.		7/12/2013
** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.